Recent studies suggest that abnormal expression of SNHG17 is associated with several tumors, including gastric cancer, non-small-cell lung cancer, colorectal cancer, melanoma, breast cancer, glioma, and tongue squamous cell carcinoma [18, 19, 21–23]. This evidence concerns the gene SNHG17 and melanoma.